Concepedia

A Marantz

AM

Statistics

Publications

4

Citations

91

H-Index

4

Active since

1985

Affiliations

National Cancer Institute(Current)

A Marantz is an author at National Cancer Institute specializing in chemotherapy, medicine, and combination chemotherapy.

ORCID

Publications per year

1985–2001

4

Publications

4

Prevention of Adriamycin-Induced Cardiotoxicity by Prenylamine: A Pilot Double Blind Study

José Milei, A Marantz, J. J. Ale et al. · Cancer Drug Delivery · 1987 · 31 citations

, , +17

A controlled trial of the effect of 4-hydroxypyrazolopyrimidine (allopurinol) on the toxicity of a single bolus dose of 5-fluorouracil.

Paul V. Woolley, Marilyn Ayoob, Frederick P. Smith et al. · Journal of Clinical Oncology · 1985 · 27 citations

, , +14

Phase II Study of Gemcitabine, 5-Fluorouracil, and Leucovorin in Patients With Pancreatic Cancer

A Marantz, S Jovtis, Luis Balbiani et al. · Seminars in Oncology · 2001 · 17 citations

, , +14

The cyclophosphamide, hexamethylmelamine, 5 fluorouracil (CHF) regimen in the treatment of advanced and recurrent ovarian cancer

Juan G. Posada, A Marantz, Kai Yeung et al. · Gynecologic Oncology · 1985 · 16 citations

, , +12

1–4 of 4